II
INNOVIVA INC
INVA· Health Care· PharmaceuticalsS&P 600
Close · 16/09/2026
21.20
1D
+1.73%52-week range
16.52 – 25.15
Volume
7,15,400.00
Price history
INVA
17/08/2026 to 16/09/2026
O 20.86 H 21.24 L 20.86
1W+0.33%
1M+1.15%
3M-6.24%
6M-3.90%
1Y+8.44%
3Y+69.60%
5Y+34.18%
MAX+61.34%
Fundamentals
as of 16/09/2026- Market cap
- $1.53B
- Shares out
- 72.25M
- P/E (trailing)
- 4.29
- P/E (forward)
- 9.35
- EPS (trailing)
- 4.94
- Beta
- 0.33
- Profit margin
- 81.19%
- P/B
- 1.24
- Return on equity
- 28.97%
SEC financial statements
56 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- INVA
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 0 buys · 2 sells · ?: 2
- 25/03/2025George WhitesidesSellInnoviva, Inc. - Common Stock$250,001–$500,000
- 24/03/2025George WhitesidesSellInnoviva, Inc. - Common Stock$50,001–$100,000